Elalfy AM. Re: Valentina Tateo, Giuseppe Basile, Patrizia Giannatempo, et al. Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer. Eur Urol 2026 Eur Urol 2026 Sep 25:S0302-2838(26)02372-9. doi: 10.1016/j.eururo.2026.
PMID: 42791106